Publication: Surgical approaches for papillary microcarcinomas: Turkey’s perspective
| dc.contributor.author | Makay, Özer | |
| dc.contributor.author | Tezelman, Serdar | |
| dc.contributor.author | Özcan, Zehra | |
| dc.contributor.author | Şenyürek, Yasemin Giles | |
| dc.contributor.author | Uludağ, Mehmet | |
| dc.contributor.author | İşgör, Adnan | |
| dc.contributor.author | Özbaş, Serdar | |
| dc.contributor.author | Özdemir, Murat | |
| dc.contributor.author | İçöz, Recep Gökhan | |
| dc.contributor.author | Tunca, Fatih | |
| dc.contributor.author | Düren, Mete | |
| dc.contributor.institution | Tanımlanmamış Kurum | |
| dc.contributor.institution | Koç Üniversitesi | |
| dc.contributor.institution | Ege Üniversitesi | |
| dc.contributor.institution | İstanbul Üniversitesi | |
| dc.contributor.institution | T.C. Sağlık Bakanlığı | |
| dc.contributor.institution | Bahçeşehir Üniversitesi | |
| dc.contributor.institution | Tanımlanmamış Kurum | |
| dc.contributor.institution | Tanımlanmamış Kurum | |
| dc.contributor.institution | Tanımlanmamış Kurum | |
| dc.contributor.institution | İstanbul Üniversitesi | |
| dc.contributor.institution | İstanbul Üniversitesi | |
| dc.date.accessioned | 2025-09-20T20:01:21Z | |
| dc.date.issued | 2018 | |
| dc.date.submitted | 10.01.2019 | |
| dc.description.abstract | Objectives: The incidence of papillary microcarcinomas, which are defined as thyroid cancers of <10mm in size,has been increasing in the last decade. Herein, we present internet-based questionnaire results performed by theTurkish Association of Endocrine Surgery with the aim to evaluate the perspective of the management of papillarymicrocarcinomas in Turkey.Material and Methods: The user-friendly questionnaire consisted of 13 questions in total. These questions mainlyaddressed the surgical management of nodules and cancer of <1 cm in size. Patient management before, during,and after surgical intervention was also included, additionally, the “active surveillance approach” was questioned.Results: There were 420 responders in total who were of multidisciplinary origin (endocrinologists, surgeons, nuclearmedicine specialists, pathologists, and oncologists). Total thyroidectomy was the predominant treatment approach(65%) for the classical type of microcarcinoma limited in one lobe, whereas in cases of microcarcinomasincidentally diagnosed during hemithyroidectomy, complementary surgery approach was advised by 40% of theresponders. The responders found capsule invasion (86%) and patient based management (94%) of high importance.The percentage of the responders who recommended radioactive iodine ablation in incidental cancers having noaggressive criteria was 51%. The survey participants that were against routine central dissection in these cases accountedfor 73% of the responders. The recommendation of active surveillance (follow-up without any interventionaltherapy) was limited with 9% responders.Conclusion: The results of the questionnaire demonstrated that there have been various choices in Turkey for thesurgical treatment of the papillary microcarcinomas. | |
| dc.identifier.doi | 10.5152/turkjsurg.2018.3596 | |
| dc.identifier.endpage | 93 | |
| dc.identifier.issn | 2564-6850 | |
| dc.identifier.issn | 2564-7032 | |
| dc.identifier.issue | 2 | |
| dc.identifier.startpage | 89 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14719/5477 | |
| dc.identifier.volume | 34 | |
| dc.language.iso | en | |
| dc.relation.journal | Turkish Journal of Surgery | |
| dc.subject | Endokrinoloji ve Metabolizma | |
| dc.subject | Cerrahi | |
| dc.title | Surgical approaches for papillary microcarcinomas: Turkey’s perspective | |
| dc.type | Research Article | |
| dcterms.references | Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated\nthyroid cancer in the United States, 1988–2005 Cancer 2009, 115:\n3801-3807.,Davies L, Welch HG. Increasing incidence of thyroid cancer in the\nUnited States, 1973-2002 JAMA 2006, 295: 2164 -2167.,Wartofsky L. Management of papillary microcarcinoma: primum non\nnocere? J Clin Endocrinol Metab. 2012, 97: 1169 -1172. [CrossRef],Haugen BR, Alexander Ek, Bible KC, Gerard M. Doherty, Susan J.\nMandel, Yuri E. Nikiforov et al. American thyroid association management\nguidelines for adult patients with thyroid nodules and\ndifferentiated thyroid cancer Thyroid. 2016, 26: 1-133. [CrossRef],Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman\nR. The importance of surgeon experience for clinical and\neconomic outcomes from thyroidectomy Ann Surg. 1998, 228:\n320-330. [CrossRef],Hay ID, Grant CS, Bergstralh EJ, Thompson GB, van Heerden JA,\nGoellner JR. Unilateral total lobectomy: is it sufficient surgical\ntreatment for patients with AMES low-risk papillary thyroid carcinoma?\nSurgery 1998, 124: 958-964. [CrossRe,Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A.\nPatient age is significantly related to the progression of papillary\nmicrocarcinoma of the thyroid under observation Thyroid 2014,\n24: 27-34. [CrossRef],Sugitani I, Toda K, Yamada K, Yamamoto N, Ikenaga M, Fujimoto\nY, Three distinctly different kinds of papillary thyroid microcarcinoma\nshould be recognized: our treatment strategies and outcomes\nWorld J Surg 2010, 34: 1222-1231. [CrossRef],Untch BR, Palmer FL, Ganly I, Patel SG, Michael TR, Shah JP et al.\nOncologic outcomes after completion thyroidectomy for patients\nwith well- differentiated thyroid carcinoma Ann Surg Oncol.\n2014, 21: 1374-1378. [CrossRef],Sancho JJ, Lennard TW, Paunovic I, Triponez F, Sitges-Serra A.\nProphylactic central neck disection in papillary thyroid cancer: a\nconsensus report of the European Society of Endocrine Surgeons\n(ESES) Langenbecks Arch Surg. 2014, 399: 155-163. [CrossRef],Lupi C, Giannini R, Uglioni C, Proietti A, Berti P, Minuto M et al. Association\nof BRAF V600E mutation with poor clinicopathological\noutcomes in 500 consecutive cases ofpapillary thyroid carcinoma\nJ Clin Endocrinol Metab. 2007, 92: 4085-4090. [CrossRef],Kim TY, Kim WB, Rhee YS, Song JY, Kim JM, Gong G et al. The BRAF\nmutation is useful for prediction of clinical recurrence in low-risk\npatients with conventional papillary thyroid carcinoma Clin En-\ndocrinol (Oxf ) 2006, 65: 364-368. [CrossRef],Xing M. Prognostic utility of BRAF mutation in papillary thyroid\ncancer Mol Cell Endocrinol. 2010, 321:86-93. [CrossRef],Schvartz C, Bonnetain F, Dabakuyo S, Gauthier M, Cueff A, Fieffe\nS et al. Impact on overall survival of radioactive iodine in low-risk\ndifferentiated thyroid cancer patients J Clin Endocrinol Metab\n2012, 97: 1526-1535. [CrossRef],Kim HJ, Kim NK, Choi JH, Kim SW, Jin SM, Suh S et al. Radioactive\niodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma Clin Endocrinol. 2013, 78: 614-\n620. [CrossRef],Miyauchi A, Kudo T, Miya A Kobayashi K, Ito Y, Takamura Y et al.\nPrognostic impact of serum thyroglobulin doubling-time under\nthyrotropin suppression in patients with papillary thyroid carcinoma\nwho underwent total thyroidectomy Thyroid 2011, 21:\n707–716.[CrossRef] | |
| dspace.entity.type | Publication | |
| local.indexed.at | TRDizin |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Surgical approaches for papillary microcarcinomas Turkey’s perspective.pdf
- Size:
- 131.2 KB
- Format:
- Adobe Portable Document Format
